Skip to main content
OpenTrials

Clinical trial condition

Genetic Diseases, Inborn

Explore clinical trials studying Genetic Diseases, Inborn. Study availability and eligibility vary by location and protocol.

12,633 public trials 2,161 recruiting studies
Refine in advanced search Browse all conditions

Genetic Diseases, Inborn trial results

Completed

A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX

NCT03366337

Conditions
Abnormalities, Multiple, Autoimmune Diseases, Autosomal Dominant Polycystic Kidney, +21 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Phoenician Centers for Research & Innovation (PCRI) Phoenix, Arizona, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Denver Nephrology Denver, Colorado, United States
View all 30 locations
View Trial Details
Completed

A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease

NCT05521191

Conditions
ADPKD, Abnormalities, Multiple, Autosomal Dominant Polycystic Kidney Disease, +13 more
Locations
  • Centricity Research Phoenix Multispecialty Mesa, Arizona, United States
  • Academic Medical Research Institute Los Angeles, California, United States
  • Yale Nephrology Outpatient Clinic New Haven, Connecticut, United States
  • Mayo Clinic - Florida Jacksonville, Florida, United States
View all 21 locations
View Trial Details
Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT03037385

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Diseases, +55 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UC Irvine Medical Center Orange, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 71 locations
View Trial Details
Completed

Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia

NCT03376438

Conditions
Arrhythmias, Cardiac, Atrial Flutter, Cardiac Conduction System Disease, +29 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • University of California, San Francisco San Francisco, California, United States
  • Children's Hospital Colorado Denver, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 41 locations
View Trial Details
Completed

Respreeza® Self-administration and Learning Program (AmAREtTI Study)

NCT04262284

Conditions
Alpha-1 Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • CHU Angers Angers, France
  • CHU Bordeaux - Hôpital Haut-Lévèque Bordeaux, France
  • CHU Grenoble-Alpes Grenoble, France
  • CHU Lille Lille, France
View Trial Details

Related conditions